About SHL Research Private Limited
Data last updated:
SHL Research Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Ns Family Consolidations Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U72100TN2002PTC050076.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Amarnath Ananthanarayanan and Vadakanchery Subramaniam Ramesh.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.9 Cathedral Road Chennai – 86., Tamil Nadu, India – 600086.
As per the financials filed for FY 2025, the company reported a revenue of ₹38,000, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹72,000 (net margin -189.5%) and EBITDA of -₹72,000 (EBITDA margin -189.5%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanmargroup.com.
Company details
CIN history
SHL Research has one previous CIN (Corporate Identification Number): U73100TN2002NPL050076. The current CIN is U72100TN2002PTC050076, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72100TN2002PTC050076 | Current |
| U73100TN2002NPL050076 | Previous |
Contact details
SHL Research Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo.9 Cathedral Road Chennai – 86., Tamil Nadu, India – 600086
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SHL Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
Financials of SHL Research Private Limited
FY 2025 filings availableSHL Research Private Limited reported revenue of ₹38,000 (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 12% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 700% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹72,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹72,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -189.5% | ||||
| Net Profit Margin | -189.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SHL Research Private Limited, buy the company report.
Board of directors of SHL Research Private Limited
SHL Research has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amarnath Ananthanarayanan Also directs: Sanmar Chemical Enterprises Limited, Greenvalley Investments (Alpha) Limited, Sanmar Holdings Limited and 1 more | Director | 23 Mar 2020 | 6 Years 7 Months | Current |
| Vadakanchery Subramaniam Ramesh | Director | 30 Jan 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving SHL Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SHL Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for SHL Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SHL Research Private Limited has 10 board changes on record since 2013: 2 appointments and 8 cessations. The latest: Vadakanchery Subramaniam Ramesh ceased to be Additional Director on 29 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
SHL Research is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 December 2002 (24+ years old) and is registered under CIN U72100TN2002PTC050076.
SHL Research has 2 current directors:
- Amarnath Ananthanarayanan - Director
- Vadakanchery Subramaniam Ramesh - Director
The latest financial statements of SHL Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of SHL Research is U72100TN2002PTC050076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SHL Research was incorporated on 23 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chennai.
Vadakanchery Subramaniam Ramesh ceased to be Additional Director on 29 Nov 2021. Mahadevan Raman ceased to be Director on 30 Jan 2021. Vadakanchery Subramaniam Ramesh was appointed as Director on 30 Jan 2021. SHL Research has 10 board changes on record in total.
SHL Research can be reached through the website sanmargroup.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of SHL Research is at No.9 Cathedral Road Chennai – 86., Tamil Nadu, India – 600086.
SHL Research operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of SHL Research is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.